CG
EPZM

Cutler Group’s Epizyme, Inc EPZM Stock Holding History

Cutler Group’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,900
Closed -$19K – 6663
2021
Q2 		$19K Hold
2,900
– – ﹤0.01% 3364
2021
Q1 		$19K Hold
2,900
– – ﹤0.01% 3279
2020
Q4 		$16K Buy
+2,900
New +$35.8K ﹤0.01% 2871
2020
Q2 		– Sell
-4,000
Closed -$7K – 5096
2020
Q1 		$7K Hold
4,000
– – ﹤0.01% 2953
2019
Q4 		$3K Buy
+4,000
New +$59.4K ﹤0.01% 3366
2018
Q3 		– Sell
-2,100
Closed -$5K – 4916
2018
Q2 		$5K Sell
2,100
-2,300
-52% -$35.8K ﹤0.01% 3173
2018
Q1 		$2K Buy
4,400
+500
+13% +$8.45K ﹤0.01% 3895
2017
Q4 		$15K Sell
3,900
-4,000
-51% -$58.1K ﹤0.01% 2831
2017
Q3 		$2K Sell
7,900
-4,700
-37% -$71.7K ﹤0.01% 5230
2017
Q2 		$18K Buy
+12,600
New +$190K ﹤0.01% 3547
2016
Q3 		– Sell
-600
Closed -$1K – 7611
2016
Q2 		$1K Buy
+600
New +$6.69K ﹤0.01% 6379

Other funds holding EPZM

Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Cutler Group's EPZM Position: Q3 2022 in Review

Cutler Group sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 2,400 shares — an estimated $3K sold.

Cutler Group first reported a position in EPZM in Q4 2015 and held it in 20 quarters. The position peaked at $116K in Q2 2017. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

  • Cutler Group reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 2,400 Epizyme, Inc shares in Q3 2022, an estimated $3K.
  • Cutler Group first reported a position in Epizyme, Inc in Q4 2015 and held it in 20 quarters.
  • Cutler Group's Epizyme, Inc position peaked at $116K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.